Phenylethanoid glycosides extract from Cistanche deserticola ameliorates atherosclerosis in apolipoprotein E-deficient mice and regulates intestinal PPARγ-LXRα-ABCA1 pathway
Journal of Pharmacy and Pharmacology · 01.05.2023 · 75 (5) · 677-685
DOI: 10.1093/jpp/rgad015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.05.2023. Verfasst von Xiubin Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, Shandong Province, People's Repu…. Hauptthemen laut MEDLINE: Atherosclerosis, Cistanche, Glycosides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Key Research and Development Projects of Shaanxi Province, Shandong First Medical University.
Abstract (Originalsprache)
Objectives
This study was aimed to evaluate the protective effects of phenylethanoid glycosides extract from Cistanche deserticola against atherosclerosis and its molecular mechanism.
Methods
Total phenylethanoid glycosides were extracted and purified from C. deserticola, and the C. deserticola extract (CDE) was used to treat a mice model of atherosclerosis. Key findings CDE containing 81.00% total phenylethanoid glycosides, with the contents of echinacoside and acteoside being 31.36% and 7.23%, respectively. A 13-week of CDE supplementation (1000 mg/kg body weight/day) significantly reduced atherosclerotic lesions in the aortic sinus and entire aorta in ApoE−/− mice fed with a high-fat diet. In addition, varying doses of CDE (250, 500 and 1000 mg/kg body weight/day) lowered plasma total cholesterol, triglyceride and non-high-density lipoprotein cholesterol levels. Transcriptomic analysis of the small intestine revealed the changes enriched in cholesterol metabolic pathway and the activation of Abca1 gene. Further validation using real-time quantitative PCR and western blot confirmed that CDE significantly increased the mRNA levels and protein expressions of ABCA1, LXRα and PPARγ.
Conclusions
Our results demonstrate the beneficial effects of C. deserticola on atherosclerotic plaques and lipid homeostasis, and it is, at least partially, by activating PPARγ-LXRα-ABCA1 pathway in small intestine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, Shandong Province, People's Republic of China.
- The Second Affiliated Hospital of Shandong First Medical University, Tai'an, Shandong Province, People's Republic of China.
ORCID-Profile: Xiubin Jia
Förderung
- Key Research and Development Projects of Shaanxi Province
- Shandong First Medical University
Zitieren
APA
Jia, X., Liu, B., Xue, J., Liu, Y., Zhang, J., Qin, S., & Zhang, Y. (2023). Phenylethanoid glycosides extract from Cistanche deserticola ameliorates atherosclerosis in apolipoprotein E-deficient mice and regulates intestinal PPARγ-LXRα-ABCA1 pathway. Journal of Pharmacy and Pharmacology, 75(5), 677-685. https://doi.org/10.1093/jpp/rgad015
Vancouver
Jia X, Liu B, Xue J, Liu Y, Zhang J, Qin S, et al. Phenylethanoid glycosides extract from Cistanche deserticola ameliorates atherosclerosis in apolipoprotein E-deficient mice and regulates intestinal PPARγ-LXRα-ABCA1 pathway. Journal of Pharmacy and Pharmacology. 2023;75(5):677-685. doi:10.1093/jpp/rgad015
BibTeX
@article{Jia2023,
author = {Jia, Xiubin and Liu, Boyan and Xue, Junli and Liu, Yunchao and Zhang, Jingjun and Qin, Shucun and Zhang, Ying},
title = {Phenylethanoid glycosides extract from Cistanche deserticola ameliorates atherosclerosis in apolipoprotein E-deficient mice and regulates intestinal PPARγ-LXRα-ABCA1 pathway},
journal = {Journal of Pharmacy and Pharmacology},
year = {2023},
volume = {75},
number = {5},
pages = {677--685},
doi = {10.1093/jpp/rgad015}
}
EUVIMED